Fernando Dangond
Impact in
- Pathology and Forensic Medicine top 0.5%
- Multiple Sclerosis Research Studies
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
Papers in
-
- Multiple Sclerosis Research Studies 51
- Genetics 19
- Chronic Lymphocytic Leukemia Research 15
- Co-authors
- David A. Hafler (4 shared papers)Gavin Giovannoni (19 shared papers)Steven G. Gray (6 shared papers)Steven R. Gullans (4 shared papers)Sandra Camelo (6 shared papers)Anja Windhagen (2 shared papers)Patrick Vermersch (19 shared papers)Stuart D. Cook (14 shared papers)
- Journals
- Neurology (18 papers)Multiple Sclerosis and Related Disorders (6 papers)Journal of Neuroimmunology (5 papers)BMC Neurology (5 papers)Multiple Sclerosis Journal (5 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Fernando Dangond
93 papers receiving 3.2k citations
Fernando Dangond's Hit Papers
Peers
Comparison fields: 5 of 104
- Pathology and Forensic Medicine 1.2k
- Neurology 300
- Neurology 515
- Immunology 705
- Genetics 300
Countries citing papers authored by Fernando Dangond
This map shows the geographic impact of Fernando Dangond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Dangond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Dangond more than expected).
Fields of papers citing papers by Fernando Dangond
This network shows the impact of papers produced by Fernando Dangond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Dangond. The network helps show where Fernando Dangond may publish in the future.
Co-authors
The 25 scholars most cited alongside Fernando Dangond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 381 | |
| 2 | 2005 | 293 | |
| 3 | 2017 | 251 | |
| 4 | Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis Hit paper breakdown → | 2019 | 245 |
| 5 | 2005 | 229 | |
| 6 | 2004 | 119 | |
| 7 | 2005 | 115 | |
| 8 | 2019 | 100 | |
| 9 | 1998 | 96 | |
| 10 | 1998 | 88 | |
| 11 | 2006 | 84 | |
| 12 | 2019 | 80 | |
| 13 | 2004 | 72 | |
| 14 | 2007 | 52 | |
| 15 | 1994 | 52 | |
| 16 | 1992 | 51 | |
| 17 | 2017 | 50 | |
| 18 | 2020 | 47 | |
| 19 | 2018 | 47 | |
| 20 | 1995 | 46 |
About Fernando Dangond
Fernando Dangond is a scholar working on Pathology and Forensic Medicine, Genetics, Molecular Biology, Oncology and Immunology, having authored 94 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (51 papers), Chronic Lymphocytic Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Protein Degradation and Inhibitors (5 papers), Polyomavirus and related diseases (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Neurology (300 citations), Neurology (515 citations), Immunology (705 citations) and Genetics (300 citations). Fernando Dangond has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include David A. Hafler, Gavin Giovannoni, Steven G. Gray, Steven R. Gullans, Sandra Camelo, Anja Windhagen, Patrick Vermersch, Stuart D. Cook, Antonio Iglesias and M. Nicola Woodroofe. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, Journal of Neuroimmunology, BMC Neurology and Multiple Sclerosis Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.